Table 5 ASSESS approach
From: Intensive care of the cancer patient: recent achievements and remaining challenges
Domain | Description and rationale |
|---|---|
Triage for ICU Admission | Triage criteria for ICU admission used by oncologists/hematologists and intensivists. Detailed evaluation of the ICU admission process, including data on non-ICU cancer patients with various levels of organ dysfunction on the wards and data on the effects of early ICU admission |
Code Status | Code status to be implemented at ICU admission: full code, ICU trial for a short period (3-5 days with full-code status and then reevaluation) or early implementation of palliative care |
ICU support and patient's evolution | ICU management, with a reappraisal of the intensity, duration and nature of life-supporting treatments provided in the ICU. Evaluation of incidence, nature and outcome of organ failures and residual organ dysfunction |
Survival | Beyond short- and medium-term survival by evaluating long-term outcomes (up to 1 year) |
Picture of survivors | Description of ICU survivors, including qualitative evaluation of the ability to undergo chemotherapy, disease-free survival, functional status, health-related quality of life and post-ICU burden (stress-related disorders, anxiety, and depression) |